References
1 Pachlopnik Schmid J, Lemoine R, Nehme N, Cormier-Daire V, Revy P,
Debeurme F et al. Polymerase ε1 mutation in a human syndrome with
facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS
syndrome”). J Exp Med 2012; 209 : 2323–2330.
2 Logan CV, Murray JE, Parry DA, Robertson A, Bellelli R, Tarnauskaitė Žet al. DNA polymerase epsilon deficiency causes IMAGe syndrome
with variable immunodeficiency. Am J Hum Genet 2018;103 : 1038–1044.
3 Takeuchi I, Tanase-Nakao K, Ogawa A, Sugawara T, Migita O, Kashima Met al. Congenital anaemia associated with loss-of-function
variants in DNA polymerase epsilon 1. J Med Genet 2023.
doi:10.1136/jmg-2023-109444.
4 Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MMet al. The 2016 revision to the World Health Organization
classification of myeloid neoplasms and acute leukemia. Blood2016; 127 : 2391–2405.
5 Locatelli F, Strahm B. How I treat myelodysplastic syndromes of
childhood. Blood 2018; 131 : 1406–1414.
6 Starý J, Locatelli F, Niemeyer CM, European Working Group on
Myelodysplastic Syndrome (EWOG-MDS) and Pediatric Diseases Working Party
of the EBMT. Stem cell transplantation for aplastic anemia and
myelodysplastic syndrome. Bone Marrow Transplant 2005; 35
Suppl 1 : S13-6.
7 Ishida S, Doki N, Shingai N, Yoshioka K, Kakihana K, Sakamaki Het al. The clinical features of fatal cyclophosphamide-induced
cardiotoxicity in a conditioning regimen for allogeneic hematopoietic
stem cell transplantation (allo-HSCT). Ann Hematol 2016;95 : 1145–1150.
8 Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MMet al. Secondary solid cancers after allogeneic hematopoietic
cell transplantation using busulfan-cyclophosphamide conditioning.Blood 2011; 117 : 316–322.
9 Nambu R, Warner N, Mulder DJ, Kotlarz D, McGovern DPB, Cho J et
al. A systematic review of monogenic inflammatory bowel disease.Clin Gastroenterol Hepatol 2022; 20 : e653–e663.
10 Elsayed FA, Kets CM, Ruano D, van den Akker B, Mensenkamp AR,
Schrumpf M et al. Germline variants in POLE are associated with
early onset mismatch repair deficient colorectal cancer. Eur J Hum
Genet 2015; 23 : 1080–1084.